Aequus Pharmaceuticals Inc. (TSXV:AQS)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Apr 25, 2025, 9:30 AM EST
Aequus Pharmaceuticals Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -0.66 | -2.18 | -2.96 | -3.21 | -1.81 | -1.05 |
Depreciation & Amortization | 0.17 | 0.13 | 0.14 | 0.13 | 0.13 | 0.21 |
Asset Writedown & Restructuring Costs | -0.03 | - | - | - | - | - |
Stock-Based Compensation | -0.02 | 0.02 | 0.05 | 0.04 | 0.22 | 0.3 |
Other Operating Activities | -0.09 | 0.06 | 0.07 | 0.64 | 0.26 | 0.25 |
Change in Accounts Receivable | -0.1 | -0.03 | 0.28 | 0.63 | -0.16 | -0.22 |
Change in Inventory | 0.09 | 0.09 | -0.03 | 0.05 | -0.02 | -0.12 |
Change in Accounts Payable | 0.46 | 0.33 | 0.03 | -0.09 | 0.14 | -0.1 |
Change in Other Net Operating Assets | 0.06 | -0.07 | 0.14 | -0.14 | 0.07 | -0.09 |
Operating Cash Flow | -0.12 | -1.66 | -2.29 | -1.95 | -1.17 | -0.8 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | - | - | - | - | -0 | -0.01 |
Other Investing Activities | 0.04 | 0.04 | - | - | - | - |
Investing Cash Flow | 0.04 | 0.04 | - | - | -0.51 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Short-Term Debt Issued | - | 1.66 | 2.37 | 2 | - | - |
Long-Term Debt Issued | - | - | - | - | - | 0.04 |
Total Debt Issued | 0.1 | 1.66 | 2.37 | 2 | - | 0.04 |
Long-Term Debt Repaid | - | -0.17 | -0.16 | -2.19 | -0.15 | -0.14 |
Net Debt Issued (Repaid) | 0.06 | 1.49 | 2.21 | -0.19 | -0.15 | -0.1 |
Issuance of Common Stock | - | - | - | - | 2.55 | 2.5 |
Other Financing Activities | - | - | - | - | -0.01 | -0.34 |
Financing Cash Flow | 0.06 | 1.49 | 2.21 | -0.19 | 2.4 | 2.05 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Cash Flow | -0.01 | -0.12 | -0.08 | -2.14 | 0.72 | 1.23 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -0.12 | -1.66 | -2.29 | -1.95 | -1.18 | -0.82 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -12.61% | -283.44% | -899.97% | -141.51% | -43.33% | -31.52% |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | 0.24 | -0.98 | -1.25 | -1.11 | -0.76 | -0.69 |
Unlevered Free Cash Flow | 0.41 | -0.82 | -1.16 | -1.03 | -0.63 | -0.51 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Interest Paid | - | - | 0.01 | 0.1 | 0.1 | - |
Change in Working Capital | 0.51 | 0.32 | 0.42 | 0.45 | 0.03 | -0.52 |